Yuri Khodjamirian
Directeur en chef des Investissements chez Tema Global Ltd.
Profil
Mr. Yuri Khodjamirian, CFA, is a Chief Investment Officer at Tema Global Ltd.
He is on the Board of Directors at Arxx Therapeutics AS.
Mr. Yuri Kohdjamirian spent over a decade at Majedie Asset Management managing UK and Global portfolios.
As co-manager of the Majedie UK Income Fund, he helped build the fund from start-up stage, raising several billion in assets.
He holds degrees in Economics from University of Cambridge and LSE (distinction), as well as a degree in Bioscience Enterprise from University of Cambridge.
He is a CFA charter holder.
Postes actifs de Yuri Khodjamirian
| Sociétés | Poste | Début |
|---|---|---|
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Directeur/Membre du Conseil | - |
Tema Global Ltd.
 Tema Global Ltd. Investment ManagersFinance Part of Dawn Global Topco Ltd., Tema Global Ltd. is a British company that is building an active thematic ETF platform. The company is based in St. Helier, UK. The platform is dedicated to designing differentiated strategies managed by experienced investment professionals. The company was founded in 2022 by Maurits Henricus Johannes Pot. | Directeur en chef des Investissements | 01/09/2022 |
Anciens postes connus de Yuri Khodjamirian
| Sociétés | Poste | Fin |
|---|---|---|
Liontrust Portfolio Management Ltd.
 Liontrust Portfolio Management Ltd. Investment ManagersFinance Liontrust Portfolio Management Ltd. (LPM) is a specialist fund management boutique headquartered in London, UK. The firm was founded in 2002 by James de Uphaugh, Chris Field, Simon Hazlitt, Rob Harris and Adam Parker. Formerly a subsidiary of Majedie Investment Plc (LSE: MAJE), the firm was acquired by Liontrust Asset Management Plc (LON: LIO) in 2022 and has been renamed under this acquisition from Majedie Asset Management Ltd. to Liontrust Portfolio Management Ltd. LPM manages equity portfolios for institutional clients. Portfolios may be structured as separate managed accounts as well as private funds. | Analyst-Equity | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Liontrust Portfolio Management Ltd.
Liontrust Portfolio Management Ltd. Investment ManagersFinance Liontrust Portfolio Management Ltd. (LPM) is a specialist fund management boutique headquartered in London, UK. The firm was founded in 2002 by James de Uphaugh, Chris Field, Simon Hazlitt, Rob Harris and Adam Parker. Formerly a subsidiary of Majedie Investment Plc (LSE: MAJE), the firm was acquired by Liontrust Asset Management Plc (LON: LIO) in 2022 and has been renamed under this acquisition from Majedie Asset Management Ltd. to Liontrust Portfolio Management Ltd. LPM manages equity portfolios for institutional clients. Portfolios may be structured as separate managed accounts as well as private funds. | Finance |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Health Technology |
Tema Global Ltd.
Tema Global Ltd. Investment ManagersFinance Part of Dawn Global Topco Ltd., Tema Global Ltd. is a British company that is building an active thematic ETF platform. The company is based in St. Helier, UK. The platform is dedicated to designing differentiated strategies managed by experienced investment professionals. The company was founded in 2022 by Maurits Henricus Johannes Pot. | Finance |
